Long term survivor of MOZ-p300 therapy-related acute myeloid leukemia after matched unrelated donor bone marrow transplantation

Leuk Lymphoma. 2023 Jul-Aug;64(7):1344-1347. doi: 10.1080/10428194.2023.2203287. Epub 2023 Apr 20.

Authors

Lubna S Mehyar¹, Leigh Hartog¹, Samir B Kahwash², Rolla Abu-Arja^{1

2}, Mark Ranalli^{1

3}, Hemalatha G Rangarajan^{1

3}

Affiliations

¹ Division of Pediatric Hematology, Oncology, Blood and Marrow Transplant, Nationwide Children's Hospital, Columbus, OH, USA.
² Department of Pathology and Laboratory Medicine, Nationwide Children's Hospital, Columbus, OH, USA.
³ Department of Pediatrics, The Ohio State University, Columbus, OH, USA.

PMID: 37081802
DOI: 10.1080/10428194.2023.2203287

No abstract available

MeSH terms

Bone Marrow Transplantation / adverse effects
Graft vs Host Disease*
Hematopoietic Stem Cell Transplantation* / adverse effects
Humans
Leukemia, Myeloid, Acute* / diagnosis
Leukemia, Myeloid, Acute* / etiology
Leukemia, Myeloid, Acute* / therapy
Survivors
Unrelated Donors